Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
101.2%
-
Total 13F principal
-
$333,367,212
-
Principal change
-
-$7,761,788
-
Total reported market value
-
$335,992,816
-
Number of holders
-
40
-
Value change
-
-$8,013,400
-
Number of buys
-
12
-
Number of sells
-
13
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q2 2015
As of 30 Jun 2015,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$333,367,212
in principal (par value) of the bond.
The largest 10 bondholders included
BAKER BROS. ADVISORS LP, Calamos Advisors LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, Davidson Kempner Capital Management LP, CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, Ameriprise Financial Inc, JPMORGAN CHASE & CO, CAMDEN ASSET MANAGEMENT L P /CA, and Polar Securities Inc..
This page lists
40
institutional bondholders reporting positions
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.